文献
J-GLOBAL ID:202002280726660526
整理番号:20A1056763
テトラヒドロウリジンを投与した静脈内5-フルオロ-2′-デオキシシチジンは進行固形腫瘍患者におけるp16発現循環腫瘍細胞の割合を増加させる【JST・京大機械翻訳】
Intravenous 5-fluoro-2′-deoxycytidine administered with tetrahydrouridine increases the proportion of p16-expressing circulating tumor cells in patients with advanced solid tumors
著者 (25件):
Coyne Geraldine O.’Sullivan
(Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA)
,
Wang Lihua
(Clinical Pharmacodynamic Biomarkers Program, Applied/Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA)
,
Zlott Jennifer
(Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA)
,
Juwara Lamin
(Clinical Monitoring Research Program, Clinical Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA)
,
Covey Joseph M.
(Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA)
,
Beumer Jan H.
(Department of Pharmaceutical Sciences, University of Pittsburgh School of Pharmacy, Pittsburgh, PA, USA)
,
Cristea Mihaela C.
(Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA, USA)
,
Newman Edward M.
(Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA, USA)
,
Koehler Stephen
(City of Hope Medical Group, South Pasadena, CA, USA)
,
Nieva Jorge J.
(University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA)
,
Garcia Agustin A.
(University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA)
,
Garcia Agustin A.
(Louisiana State University, New Orleans, LA, USA)
,
Gandara David R.
(University of California Davis Cancer Center, Sacramento, CA, USA)
,
Miller Brandon
(Clinical Pharmacodynamic Biomarkers Program, Applied/Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA)
,
Khin Sonny
(Clinical Pharmacodynamic Biomarkers Program, Applied/Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA)
,
Miller Sarah B.
(Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA)
,
Steinberg Seth M.
(Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA)
,
Rubinstein Larry
(Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA)
,
Parchment Ralph E.
(Clinical Pharmacodynamic Biomarkers Program, Applied/Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA)
,
Kinders Robert J.
(Clinical Pharmacodynamic Biomarkers Program, Applied/Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA)
,
Piekarz Richard L.
(Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA)
,
Kummar Shivaani
(Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA)
,
Chen Alice P.
(Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA)
,
Doroshow James H.
(Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA)
,
Doroshow James H.
(Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA)
資料名:
Cancer Chemotherapy and Pharmacology
(Cancer Chemotherapy and Pharmacology)
巻:
85
号:
5
ページ:
979-993
発行年:
2020年
JST資料番号:
W4134A
ISSN:
1432-0843
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
ドイツ (DEU)
言語:
英語 (EN)